TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 77 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GOSS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
348 312 259 373 351 315 281 241 209 172 129 77
341 307 255 371 344 310 275 236 204 168 125 73
83 32 39 87 28 46 29 26 8.9 38 41 41
329 296 244 354 327 295 258 213 180 137 99 57
– – – 3.6 6.6 5.3 6.6 8.0 9.6 13 9.4 6.1
243 249 233 292 297 286 287 287 291 295 290 171
42 52 36 45 51 45 48 54 62 63 57 138
15 15 12 1.8 1.7 1.0 0.9 0.9 0.9 0.9 1.0 36
1.3 5.5 2.7 1.0 3.1 2.3 3.4 1.9 1.1 6.0 11 6.0
200 197 197 197 197 198 198 198 198 199 199 –
105 63 27 82 54 29 -6.3 -46 -82 -123 -161 -94
-1,164 -1,212 -1,254 -1,205 -1,236 -1,269 -1,305 -1,343 -1,392 -1,439 -1,486 -1,469
193 225 226 239 226 227 227 227 2.8 2.8 2.9 4.1

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?